SlideShare ist ein Scribd-Unternehmen logo
1 von 22
ROSEMBERG  GALEANO
DESCRIPCION ,[object Object]
FUENTE Y CADENAS DE TRASMISION Fuente:  Animales y personas infectadas Afecta principalmente los sistemas respiratorios, linfático, renal, digestivo y el SNC Cadena de trasmisión: Agente causal Un reservorio o fuente de infección Mecanismo de transmisión Un huésped susceptible de enfermar.
FUENTE  Y  CADENA  DE  TRASMISION
EPIDEMIOLOGIA La organización mundial de la salud (OMS) señala que un tercio de la población mundial esta infectada por M. tuberculosis; cada año ocurre 8 millones de casos nuevos y tres millones de funciones por TBC. Clasificándola como una enfermedad re emergente y en algunas regiones del mundo considerándole una enfermedad persistente. INDICADORES EPIDEMIOLOGICOS BASICOS: Incidencia Prevalecía Mortalidad Riesgo de infección
 
SIGNOS Y SINTOMAS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
APARIENCIA  FISICA
ESPECTRO NATURAL DE LA TUBERCULOSIS
PATOGENIA
[object Object],[object Object]
[object Object],[object Object],[object Object]
 
ARTICULOS CIENTIFICOS
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
REFERENCIAS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
BIBLIOGRAFIA ,[object Object],[object Object],[object Object]
GRACIAS

Weitere ähnliche Inhalte

Was ist angesagt?

BRN Symposium 03/06/16 The respiratory microbiome: a new frontier in medicine
BRN Symposium 03/06/16 The respiratory microbiome: a new frontier in medicineBRN Symposium 03/06/16 The respiratory microbiome: a new frontier in medicine
BRN Symposium 03/06/16 The respiratory microbiome: a new frontier in medicine
brnmomentum
 
Pulmmonary tuberculosis
Pulmmonary tuberculosisPulmmonary tuberculosis
Pulmmonary tuberculosis
Erasto Umoja
 
Lurking in the dark latent tuberculosis infection ijmds jan 2014
Lurking in the dark latent tuberculosis infection   ijmds jan 2014Lurking in the dark latent tuberculosis infection   ijmds jan 2014
Lurking in the dark latent tuberculosis infection ijmds jan 2014
Sachin Adukia
 
Infections in immunocompromised patients
Infections in immunocompromised patientsInfections in immunocompromised patients
Infections in immunocompromised patients
جهاد الخريصي
 
The Interaction between TB and HIV
The Interaction between TB and HIVThe Interaction between TB and HIV
The Interaction between TB and HIV
meducationdotnet
 

Was ist angesagt? (20)

Tb TUBERCULOSIS
Tb TUBERCULOSISTb TUBERCULOSIS
Tb TUBERCULOSIS
 
BRN Symposium 03/06/16 The respiratory microbiome: a new frontier in medicine
BRN Symposium 03/06/16 The respiratory microbiome: a new frontier in medicineBRN Symposium 03/06/16 The respiratory microbiome: a new frontier in medicine
BRN Symposium 03/06/16 The respiratory microbiome: a new frontier in medicine
 
Tuberculosis TB
Tuberculosis TBTuberculosis TB
Tuberculosis TB
 
TUBERCULOSIS
TUBERCULOSISTUBERCULOSIS
TUBERCULOSIS
 
Tuberculosis97.06.19
Tuberculosis97.06.19Tuberculosis97.06.19
Tuberculosis97.06.19
 
Pulmmonary tuberculosis
Pulmmonary tuberculosisPulmmonary tuberculosis
Pulmmonary tuberculosis
 
pulmonary tuberculosis
pulmonary tuberculosispulmonary tuberculosis
pulmonary tuberculosis
 
TUBERCULOSIS
TUBERCULOSISTUBERCULOSIS
TUBERCULOSIS
 
Immunocompromised patient with sepsis
Immunocompromised patient with sepsisImmunocompromised patient with sepsis
Immunocompromised patient with sepsis
 
Viral infections associated with immunosuppressive therapy edited
Viral infections associated with immunosuppressive therapy editedViral infections associated with immunosuppressive therapy edited
Viral infections associated with immunosuppressive therapy edited
 
Lurking in the dark latent tuberculosis infection ijmds jan 2014
Lurking in the dark latent tuberculosis infection   ijmds jan 2014Lurking in the dark latent tuberculosis infection   ijmds jan 2014
Lurking in the dark latent tuberculosis infection ijmds jan 2014
 
Tuberculosis (TB): clinical background,diagnosis and management
Tuberculosis (TB): clinical background,diagnosis and managementTuberculosis (TB): clinical background,diagnosis and management
Tuberculosis (TB): clinical background,diagnosis and management
 
Infections in Immunocompromised Pts
Infections in Immunocompromised PtsInfections in Immunocompromised Pts
Infections in Immunocompromised Pts
 
Infections in immunocompromised patients
Infections in immunocompromised patientsInfections in immunocompromised patients
Infections in immunocompromised patients
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Pharmacotherapy of Tuberculosis
Pharmacotherapy of TuberculosisPharmacotherapy of Tuberculosis
Pharmacotherapy of Tuberculosis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
The Interaction between TB and HIV
The Interaction between TB and HIVThe Interaction between TB and HIV
The Interaction between TB and HIV
 
Neutropenia febril
Neutropenia febrilNeutropenia febril
Neutropenia febril
 
Deciphering drug resistance in mtb using wgs
Deciphering drug resistance in mtb using wgsDeciphering drug resistance in mtb using wgs
Deciphering drug resistance in mtb using wgs
 

Andere mochten auch

Shalgalt open office presentation(3)
Shalgalt open office presentation(3)Shalgalt open office presentation(3)
Shalgalt open office presentation(3)
Amarzaya84
 
цахим судалгаа
цахим судалгаа цахим судалгаа
цахим судалгаа
Zaya80
 
Chapter3.7
Chapter3.7Chapter3.7
Chapter3.7
nglaze10
 
Chapter4.7
Chapter4.7Chapter4.7
Chapter4.7
nglaze10
 
Noordelijk Marketingdebat - de stellingen
Noordelijk Marketingdebat - de stellingenNoordelijk Marketingdebat - de stellingen
Noordelijk Marketingdebat - de stellingen
La Compagnie
 
зурагт үзүүлэн1
зурагт үзүүлэн1зурагт үзүүлэн1
зурагт үзүүлэн1
Zaya80
 
Chapter1.9
Chapter1.9Chapter1.9
Chapter1.9
nglaze10
 

Andere mochten auch (20)

Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
16 mar15 final ppt presentation - incomplete
16 mar15   final ppt presentation - incomplete16 mar15   final ppt presentation - incomplete
16 mar15 final ppt presentation - incomplete
 
Zberiga
ZberigaZberiga
Zberiga
 
Shalgalt open office presentation(3)
Shalgalt open office presentation(3)Shalgalt open office presentation(3)
Shalgalt open office presentation(3)
 
CUtopia: Online Banking
CUtopia: Online BankingCUtopia: Online Banking
CUtopia: Online Banking
 
Nihonggo Powerpoint Presentation
Nihonggo Powerpoint PresentationNihonggo Powerpoint Presentation
Nihonggo Powerpoint Presentation
 
Nihonggo Powerpoint Presentation
Nihonggo Powerpoint PresentationNihonggo Powerpoint Presentation
Nihonggo Powerpoint Presentation
 
цахим судалгаа
цахим судалгаа цахим судалгаа
цахим судалгаа
 
Chapter3.7
Chapter3.7Chapter3.7
Chapter3.7
 
Chapter4.7
Chapter4.7Chapter4.7
Chapter4.7
 
Active ageing and technology
Active ageing and technologyActive ageing and technology
Active ageing and technology
 
Aji amarillo
Aji amarilloAji amarillo
Aji amarillo
 
10.3
10.310.3
10.3
 
Noordelijk Marketingdebat - de stellingen
Noordelijk Marketingdebat - de stellingenNoordelijk Marketingdebat - de stellingen
Noordelijk Marketingdebat - de stellingen
 
Email Split Testing is Essential for Profitability
Email Split Testing is Essential for ProfitabilityEmail Split Testing is Essential for Profitability
Email Split Testing is Essential for Profitability
 
Managing Social Media Message, Delivery & Interactions
Managing Social Media  Message, Delivery & InteractionsManaging Social Media  Message, Delivery & Interactions
Managing Social Media Message, Delivery & Interactions
 
Crown tank-co 6-1
Crown tank-co 6-1Crown tank-co 6-1
Crown tank-co 6-1
 
Walla Faces Vineyards
Walla Faces VineyardsWalla Faces Vineyards
Walla Faces Vineyards
 
зурагт үзүүлэн1
зурагт үзүүлэн1зурагт үзүүлэн1
зурагт үзүүлэн1
 
Chapter1.9
Chapter1.9Chapter1.9
Chapter1.9
 

Ähnlich wie Tuberculosis

Impact of tuberculosis pathogenesis and management
Impact of tuberculosis pathogenesis and managementImpact of tuberculosis pathogenesis and management
Impact of tuberculosis pathogenesis and management
drhrshitjain
 

Ähnlich wie Tuberculosis (20)

Pulmonary tuberculoma
Pulmonary tuberculomaPulmonary tuberculoma
Pulmonary tuberculoma
 
Tuberclosis pharmacotherapy
Tuberclosis pharmacotherapyTuberclosis pharmacotherapy
Tuberclosis pharmacotherapy
 
tuberculosis .pptx
tuberculosis .pptxtuberculosis .pptx
tuberculosis .pptx
 
tuberculosis (2).pptx
tuberculosis (2).pptxtuberculosis (2).pptx
tuberculosis (2).pptx
 
Pathogenesis of tuberculosis
Pathogenesis of tuberculosis Pathogenesis of tuberculosis
Pathogenesis of tuberculosis
 
Anti TB drugs
Anti TB drugsAnti TB drugs
Anti TB drugs
 
Childhood tuberculosis diagonosis and its management
Childhood tuberculosis diagonosis and its managementChildhood tuberculosis diagonosis and its management
Childhood tuberculosis diagonosis and its management
 
mycobacteria -TB.ppt- laboratory medicine
mycobacteria -TB.ppt- laboratory medicinemycobacteria -TB.ppt- laboratory medicine
mycobacteria -TB.ppt- laboratory medicine
 
Impact of tuberculosis pathogenesis and management
Impact of tuberculosis pathogenesis and managementImpact of tuberculosis pathogenesis and management
Impact of tuberculosis pathogenesis and management
 
PPT Scarpellini "TB and HIV positive people"
PPT Scarpellini "TB and HIV positive people"PPT Scarpellini "TB and HIV positive people"
PPT Scarpellini "TB and HIV positive people"
 
Tuberculosis MBBS FIRST YEAR MICROBIOLOGY
Tuberculosis MBBS FIRST YEAR MICROBIOLOGYTuberculosis MBBS FIRST YEAR MICROBIOLOGY
Tuberculosis MBBS FIRST YEAR MICROBIOLOGY
 
Tuberculosis by Faith Chelang'at
Tuberculosis by Faith Chelang'atTuberculosis by Faith Chelang'at
Tuberculosis by Faith Chelang'at
 
Tuberculosis 2.pptx
Tuberculosis 2.pptxTuberculosis 2.pptx
Tuberculosis 2.pptx
 
A Case of Mycobacterium Abscessus in an Immunocompetent Patient
A Case of Mycobacterium Abscessus in an Immunocompetent PatientA Case of Mycobacterium Abscessus in an Immunocompetent Patient
A Case of Mycobacterium Abscessus in an Immunocompetent Patient
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Paediatric TB.ppt
Paediatric TB.pptPaediatric TB.ppt
Paediatric TB.ppt
 
Mycobacterium tuberculosis and Mycobacterium leprae
Mycobacterium tuberculosis and Mycobacterium leprae Mycobacterium tuberculosis and Mycobacterium leprae
Mycobacterium tuberculosis and Mycobacterium leprae
 
Tuberculosis - World TB Day 2011
Tuberculosis - World TB Day 2011Tuberculosis - World TB Day 2011
Tuberculosis - World TB Day 2011
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Pulmonary Tuberculosis Presentation
Pulmonary Tuberculosis PresentationPulmonary Tuberculosis Presentation
Pulmonary Tuberculosis Presentation
 

Tuberculosis

  • 2.
  • 3. FUENTE Y CADENAS DE TRASMISION Fuente: Animales y personas infectadas Afecta principalmente los sistemas respiratorios, linfático, renal, digestivo y el SNC Cadena de trasmisión: Agente causal Un reservorio o fuente de infección Mecanismo de transmisión Un huésped susceptible de enfermar.
  • 4. FUENTE Y CADENA DE TRASMISION
  • 5. EPIDEMIOLOGIA La organización mundial de la salud (OMS) señala que un tercio de la población mundial esta infectada por M. tuberculosis; cada año ocurre 8 millones de casos nuevos y tres millones de funciones por TBC. Clasificándola como una enfermedad re emergente y en algunas regiones del mundo considerándole una enfermedad persistente. INDICADORES EPIDEMIOLOGICOS BASICOS: Incidencia Prevalecía Mortalidad Riesgo de infección
  • 6.  
  • 7.
  • 9. ESPECTRO NATURAL DE LA TUBERCULOSIS
  • 11.
  • 12.
  • 13.  
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.